by Proactive LTC Consulting | May 28, 2025 | Clinical, Compliance, F-Tag, Pharmacy, Regulatory, Survey
Q: What are the most common reasons for the citing of F761 – Storage of Drugs and Biologicals? A: In Appendix PP the regulatory guidance for F761 is as follows: §483.45(g) Labeling of Drugs and Biologicals Drugs and biologicals used in the facility must be... by Proactive LTC Consulting | Feb 5, 2025 | Activities, ADL, Clinical, Quality
Family Engagement in LTC: Building Bridges for Better Care Family engagement plays an important role in enhancing the quality of life for nursing home residents. While nursing homes provide essential medical care and support, the involvement of families can... by Proactive LTC Consulting | Jan 7, 2025 | Abuse, Clinical, Falls, Infection Prevention, Legal, Nursing, Pressure Ulcers, Regulatory
Long-Term Care Litigation: Evolving Challenges and Proactive Solutions Long Term Care (LTC) litigation has transformed into a highly focused and increasingly intimidating process for facilities. Providers can reduce litigation risk by understanding the LTC litigation... by Proactive LTC Consulting | Dec 22, 2024 | Admissions, Clinical, Compliance, Documentation, Facility Assessment, Nursing, Therapy
Keys to Effective Pre-Admission Screening Ensuring that your facility is a good fit for prospective residents (and they are a good fit for your facility) is critical for delivering high-quality care and maintaining operational efficiency. A thorough and structured... by Proactive LTC Consulting | Dec 17, 2024 | 5-Star, Clinical, Compliance, QA, QAPI, Quality Measure
Tips for Writing Effective Performance Improvement Plans (PIPs) Performance Improvement Projects (PIPs) are critical to driving quality improvement and ensuring compliance in skilled nursing facilities. A well-structured PIP not only identifies areas for improvement,... by Proactive LTC Consulting | Oct 30, 2024 | Clinical, Coding, Compliance, MDS, Nursing, RAI Manual
Q: I have a resident that routinely receives an injection of fluphenazine decanoate every 4 weeks. The injection was not administered during the 7-day observation period, but its a long-lasting medication. Should I code it under N0415A? A: Page N-9 of...